Advertisement
Screener

CYTOKINETICS, INCORPORATED (CYTK) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

2.6 / 5 stars · 49/94 Roast Me

CYTOKINETICS, INCORPORATED Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

CYTOKINETICS, INCORPORATED (CYTK) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 27.45 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06

  • CYTOKINETICS, INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 30.64M shares, a 14.10% increase year-over-year.
  • CYTOKINETICS, INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 26.85M shares, a 5.61% increase year-over-year.
  • CYTOKINETICS, INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 25.43M shares, a 3.82% decline year-over-year.
  • CYTOKINETICS, INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 26.44M shares, a 9.24% decline year-over-year.
  • CYTOKINETICS, INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 29.17M shares, a 17.28% increase from fiscal 2024.
  • CYTOKINETICS, INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 24.88M shares, a 3.43% decline from fiscal 2023.
  • CYTOKINETICS, INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 25.76M shares, a 3.65% increase from fiscal 2022.
  • CYTOKINETICS, INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 24.85M shares, a 9.69% decline from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-3027.45M shares
10-Q · filed 2026-08-06
2026-03-3130.64M shares
10-Q · filed 2026-05-05
2025-12-3129.17M shares
10-K · filed 2026-02-26
2025-09-3029.79M shares
10-Q · filed 2025-11-05
2025-06-3026.66M shares
10-Q · filed 2026-08-06
2025-03-3126.85M shares
10-Q · filed 2026-05-05
2024-12-3124.88M shares
10-K · filed 2026-02-26
2024-09-3025.18M shares
10-Q · filed 2025-11-05
2024-06-3025.28M shares
10-Q · filed 2025-08-07
2024-03-3125.43M shares
10-Q · filed 2025-05-06
2023-12-3125.76M shares
10-K · filed 2026-02-26
2023-09-3026.22M shares
10-Q · filed 2024-11-07		29.94M shares
10-Q · filed 2023-11-03
2023-06-3026.34M shares
10-Q · filed 2024-08-09		30.06M shares
10-Q · filed 2023-08-03
2023-03-3126.44M shares
10-Q · filed 2024-05-10		26.99M shares
10-Q · filed 2023-05-05
2022-12-3124.85M shares
10-K · filed 2025-02-27		25.40M shares
10-K · filed 2023-03-01
2022-09-3025.29M shares
10-Q · filed 2023-11-03
2022-06-3029.05M shares
10-Q · filed 2023-08-03
2022-03-3129.13M shares
10-Q · filed 2023-05-05
2021-12-3127.52M shares
10-K · filed 2024-02-28
2021-09-3027.79M shares
10-Q · filed 2022-11-04
2021-06-3027.76M shares
10-Q · filed 2022-08-05
2021-03-3127.43M shares
10-Q · filed 2022-05-06
2020-12-3126.36M shares
10-K · filed 2023-03-01
2020-09-3026.70M shares
10-Q · filed 2021-11-05
2020-06-3026.87M shares
10-Q · filed 2021-08-06
2020-03-3127.15M shares
10-Q · filed 2021-05-07
2019-12-3125.46M shares
10-K · filed 2022-02-25
2019-09-308.89M shares
10-Q · filed 2020-11-06
2019-06-308.77M shares
10-Q · filed 2020-08-07
2019-03-316.95M shares
10-Q · filed 2020-05-08
2018-12-316.25M shares
10-K · filed 2021-02-26
2018-09-306.15M shares
10-Q · filed 2019-11-01
2018-06-306.13M shares
10-Q · filed 2019-08-09
2018-03-315.86M shares
10-Q · filed 2019-05-09
2017-12-316.53M shares
10-K · filed 2019-03-07
2017-09-306.62M shares
10-Q · filed 2017-11-03		6.62M shares
10-Q · filed 2018-11-09
2017-06-306.96M shares
10-Q · filed 2017-08-04		6.96M shares
10-Q · filed 2018-08-07
2017-03-3110.26M shares
10-Q · filed 2018-05-10
2016-12-313.69M shares
10-K · filed 2018-03-05
2016-09-302.00M shares
10-Q · filed 2017-11-03		3.71M shares
10-Q · filed 2017-11-03
2016-06-3012.49M shares
10-Q · filed 2017-08-04		12.49M shares
10-Q · filed 2017-08-04
2016-03-3112.38M shares
10-Q · filed 2017-05-04
2015-12-3111.25M shares
10-K · filed 2018-03-05
2015-09-309.87M shares
10-Q/A · filed 2016-12-15		9.87M shares
10-Q/A · filed 2016-12-15
2015-06-3010.21M shares
10-Q · filed 2015-08-05		10.21M shares
10-Q · filed 2016-08-04
2015-03-3111.36M shares
10-Q · filed 2016-05-05
2014-12-3110.07M shares
10-K · filed 2017-03-06
2014-09-3010.09M shares
10-Q · filed 2014-11-06		10.09M shares
10-Q · filed 2015-11-05
2014-06-3010.09M shares
10-Q · filed 2014-08-07		10.09M shares
10-Q · filed 2015-08-05		11.12M shares
10-Q · filed 2014-08-07
2014-03-3111.04M shares
10-Q · filed 2015-05-04
2013-12-3110.20M shares
10-K · filed 2016-03-03		10.20M shares
10-K · filed 2014-03-07
2013-09-3010.22M shares
10-Q · filed 2013-11-06		10.22M shares
10-Q · filed 2014-11-06
2013-06-3011.12M shares
10-Q · filed 2013-08-07
2013-03-3114.91M shares
10-Q · filed 2014-05-07		89.47M shares
10-Q · filed 2013-05-08
2012-12-3114.87M shares
10-K · filed 2015-03-06		89.19M shares
10-K · filed 2013-03-15
2012-09-3089.47M shares
10-Q · filed 2012-11-07		14.91M shares
10-Q · filed 2013-11-06		89.47M shares
10-Q · filed 2012-11-07
2012-06-3099.33M shares
10-Q · filed 2012-08-06		16.55M shares
10-Q · filed 2013-08-07		99.33M shares
10-Q · filed 2012-08-06
2012-03-3129.29M shares
10-Q · filed 2013-05-08
2011-12-314.58M shares
10-K · filed 2014-03-07		27.50M shares
10-K · filed 2013-03-15
2011-09-3028.29M shares
10-Q · filed 2012-11-07		28.29M shares
10-Q · filed 2012-11-07
2011-06-3028.34M shares
10-Q · filed 2012-08-06		28.34M shares
10-Q · filed 2012-08-06
2010-12-3112.16M shares
10-K · filed 2013-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Alkermes plc. (ALKS)$6.844B132.74
Advertisement